Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, July 28, 2014

Merck Initiates Phase 3 Study of Letermovir for Prevention of Cytomegalovirus (CMV) Infection

July 24, 2014 -- Merck, known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in a global Phase 3 clinical study of letermovir , an investigational antiviral agent.

http://ift.tt/1uxtGq6?
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts